Nov 05,2018

Oncology Analytics Raises $21M Series B

Atlanta-based Oncology Analytics has closed on a $21 million Series B funding round led by Oak HC/FT. New investor McKesson Ventures, along with returning investors Blue Cross Blue Shield Venture Partners and Sandbox Advantage Fund, also participated in the �oversubscribed� financing. Combined with a $7.5 million Series A raise in March 2016, the company has raised a total of $28.5 million.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Feb 20,2019

AI-company Aidence raises €10 million Series A to revolutionise the medical imaging industry

Aidence, a company that is bringing the full potential of Artificial Intelligence into the hands of medical professionals in medical imaging and disease detection, has completed a €10 million Series A funding round. The round was led by INKEF Capital and co-investor Rabo Ventures, alongside existing investors Northzone, HenQ and Health Innovations. This investment brings Aidence's total funding to €12.5 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 07,2019

Owkin Closes New Round Led by F-Prime

Owkin, a NYC-based company which builds machine learning technologies and infrastructure to enable medical research, received a funding round of undisclosed amount. The round was led by F-Prime Capital and Eight Roads Ventures, joined by GV, Cathay Innovation and NJF Capital. In conjunction with the funding, Alex Pasteur, Partner at F-Prime Capital, joined Owkin�s board. The company intends to use the funds to expand its partner network worldwide and deploy its flagship machine learning platform to augment medical research.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 09,2019

18 Startups Selected for Batch Two of the "Insurtech Europe powered by Plug and Play" Program

Insurtech Europe, Plug and Play's Insurtech platform based in Munich, Germany, announced today the 18 startups have been selected for its second batch. One of the startups, Fosanis, supports cancer patients coping with their mental and medical challenges through their digital Mika App.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 17,2019

PathAI Secures $60M in Series B Funding

PathAI, a Boston, MA-based global provider of artificial intelligence-powered technology for pathology, raised $60m in Series B funding. The round was led by new investor General Atlantic, with participation from General Catalyst and other existing investors. In conjunction with the funding, General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI�s board of directors.The company intends to use the funds to: � enhance offerings to existing partners, � drive continuous improvement of its flagship pathology research platform, � meet market demands, and � accelerate research and development into new tools and medical devices.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 08,2019

LetsGetChecked raises $30 million for at-home medical tests

The fresh cash brings LetsGetChecked�s total raised to roughly $48.9 million, following a $14.5 million series A raise in July 2016. CEO and founder Peter Foley said the company will use the funds to scale its diagnostics products in the U.S. and internationally, further develop its technology platform, and expand its U.S. manufacturing and logistics operations.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 21,2019

SkinIO has raised $500K

SkinIO, a healthcare technology company that specializes in skin cancer screening and tracking, has raised $500,000 USD through a private offering of securities.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
May 30,2019

Cancer-Fighting Startup Tempus Raises $200M at a $3B Valuation

Eric Lefkofsky's genomic-sequencing startup Tempus has raised another massive round of funding as it brings its cancer-fighting tech to new therapeutic areas. Tempus announced Thursday that it raised $200 million in a Series F round that values the Chicago startup at $3.1 billion. The fundraise comes less than a year after Tempus raised $110 million at a $2 billion valuation.

FUNDING SERIES F
View Analyst & Ambassador Comments
Go to original news
Jun 16,2019

Optellum scores £1 million in funding from Luminous Ventures to tackle lung cancer diagnosis with AI

Oxford-based Optellum, which offers AI software for early lung cancer diagnosis and treatment, has just raised £1 million from Luminous Ventures, as part of a seed follow-on round of £3.25 million. London-based Luminous Ventures’ investment is part of a round that also includes IQ Capital, St. John's College, Oxford and the family office of Sir Martin & Lady Audrey Wood.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jul 09,2019

Cigna Ventures leads $23M funding round in precision medicine company GNS Healthcare

GNS Healthcare has raised $23 million in a series D fundraising round led by Cigna Ventures, the corporate venture fund of global health service company Cigna. Joining the funding round were Amgen Ventures, Celgene, Echo Health Ventures and Alexandria Venture Investments, as well as former Caesar�s CEO and Aetna Division President Gary Loveman. GNS is the first insights- and analytics-focused investment Cigna Ventures has announced since the fund launched.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING